# The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

> **NCT00739297** · PHASE1 · COMPLETED · sponsor: **Organon and Co** · enrollment: 68 (actual)

## Conditions studied

- Chronic Asthma

## Interventions

- **DRUG:** Comparator: montelukast
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00739297
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00739297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00739297, "The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00739297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*